Medical Oddities: A Cancer Clue Some Patients Can’t See
This week’s science roundup shows how hidden signals can shape real outcomes.
-
By
-
Teraya Smith
-
January 21, 2026
-
Clinical Scorecard: Medical Oddities: A Cancer Clue Some Patients Can’t See
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Patients with bladder cancer and color vision deficiency (CVD) |
| Care Setting | |
Key Highlights
- CVD linked to a 52% higher 20-year mortality rate specifically in bladder cancer patients.
Guideline-Based Recommendations
Diagnosis
Management
- Monitor bladder cancer patients with CVD closely for survival outcomes.
- Consider CVD status in colorectal cancer management strategies.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients diagnosed with bladder or colorectal cancer
Awareness of CVD may alter clinical suspicion and management strategies.
Clinical Best Practices
- Educate patients with CVD about the importance of reporting any urinary symptoms.
- Implement routine screening for colorectal cancer starting at age 45.
- Monitor CVD status in colorectal cancer patients.
Related Resources & Content
